Lawrence H. Boise, PhD | Authors

DETROIT MEDICAL CTR

1300 BEAUBIEN ST

Articles

Current Advances in Novel Proteasome Inhibitor–Based Approaches to the Treatment of Relapsed/Refractory Multiple Myeloma

November 15, 2011

The introduction of new therapies has led to improved survival of patients with multiple myeloma (MM), even those with relapsed and/or refractory (R/R) disease.